PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes

NCT02506647 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Gan & Lee insulin glargine followed by Lantus
DRUG: Lantus followed by Gan & Lee insulin glargine

Sponsor

Gan and Lee Pharmaceuticals, USA